GRCE NASDAQ · Healthcare · FY 2026-03-31

Grace Therapeutics, Inc.

0.00.61.11.72.2ABVfair 0.91buy ≤ 0.32EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 2.08 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
No-Moat
Confidence
●○○ Low · 1/4

Price
2.080 USD
Market cap
33.3M USD
P / B
0.52
P / E
EPS
-0.486
DPS / yield
(0.0%)
NAV / share
0.913
Graham number
Z'' score
13.53
Piotroski F
1 / 9
Beneish M
ROIC vs WACC
-21.5% vs 6.9%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.